Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression

T. Leslie, Noemi Lois, Dina Christopoulou, J. A. Olson, John Vincent Forrester

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Aim: To report on visual and angiographic outcomes of a consecutive series of patients with inflammatory choroidal neovascular membranes (CNV) unresponsive to systemic immunosuppression treated with photodynamic therapy (PDT).

Methods: The medical records of six consecutive patients with inflammatory CNVs that failed to respond to systemic immunosuppression and that later underwent PDT were retrospectively reviewed. Patient demographics, visual acuity, and fluorescein angiographic findings were evaluated.

Results: There were five females and one male with a mean age of 40.8 years (range 35-58 years). Four patients had clinical features consistent with punctate inner choroidopathy and two with presumed ocular histoplasmosis. In all cases clinical signs of CNV activity, including subretinal fluid, subretinal blood, hard exudates, and/or recent decrease in visual acuity were present prior to PDT. All patients had been treated with high dose systemic immunosuppressants, which failed to induce regression of the CNV and/or to improve vision. The CNVs were subfoveal in five patients and juxtafoveal in one; all were classified as predominantly classic. Following PDT an improvement in vision occurred in all cases ( median improvement of 18 letters, range 3-42 letters). At last follow up, signs of decreased activity in the CNV were detected in all cases. Patients were followed for a median of 10 months (range 9-20 months).

Conclusion: PDT appears to be a useful option in the management of patients with inflammatory CNVs unresponsive to immunosuppressive therapies.

Original languageEnglish
Pages (from-to)147-150
Number of pages3
JournalBritish Journal of Ophthalmology
Volume89
DOIs
Publication statusPublished - 2005

Keywords

  • OCULAR HISTOPLASMOSIS SYNDROME
  • PUNCTATE INNER CHOROIDOPATHY
  • RANDOMIZED CLINICAL-TRIALS
  • ANGIOID STREAKS
  • MULTIFOCAL CHOROIDITIS
  • LASER PHOTOCOAGULATION
  • VISUAL PROGNOSIS
  • SURGICAL REMOVAL
  • SUBFOVEAL
  • VERTEPORFIN

Cite this

Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. / Leslie, T.; Lois, Noemi; Christopoulou, Dina; Olson, J. A.; Forrester, John Vincent.

In: British Journal of Ophthalmology, Vol. 89, 2005, p. 147-150.

Research output: Contribution to journalArticle

Leslie, T. ; Lois, Noemi ; Christopoulou, Dina ; Olson, J. A. ; Forrester, John Vincent. / Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. In: British Journal of Ophthalmology. 2005 ; Vol. 89. pp. 147-150.
@article{c7ea279376ad4d0cb3e55ca72ccb72c7,
title = "Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression",
abstract = "Aim: To report on visual and angiographic outcomes of a consecutive series of patients with inflammatory choroidal neovascular membranes (CNV) unresponsive to systemic immunosuppression treated with photodynamic therapy (PDT).Methods: The medical records of six consecutive patients with inflammatory CNVs that failed to respond to systemic immunosuppression and that later underwent PDT were retrospectively reviewed. Patient demographics, visual acuity, and fluorescein angiographic findings were evaluated.Results: There were five females and one male with a mean age of 40.8 years (range 35-58 years). Four patients had clinical features consistent with punctate inner choroidopathy and two with presumed ocular histoplasmosis. In all cases clinical signs of CNV activity, including subretinal fluid, subretinal blood, hard exudates, and/or recent decrease in visual acuity were present prior to PDT. All patients had been treated with high dose systemic immunosuppressants, which failed to induce regression of the CNV and/or to improve vision. The CNVs were subfoveal in five patients and juxtafoveal in one; all were classified as predominantly classic. Following PDT an improvement in vision occurred in all cases ( median improvement of 18 letters, range 3-42 letters). At last follow up, signs of decreased activity in the CNV were detected in all cases. Patients were followed for a median of 10 months (range 9-20 months).Conclusion: PDT appears to be a useful option in the management of patients with inflammatory CNVs unresponsive to immunosuppressive therapies.",
keywords = "OCULAR HISTOPLASMOSIS SYNDROME, PUNCTATE INNER CHOROIDOPATHY, RANDOMIZED CLINICAL-TRIALS, ANGIOID STREAKS, MULTIFOCAL CHOROIDITIS, LASER PHOTOCOAGULATION, VISUAL PROGNOSIS, SURGICAL REMOVAL, SUBFOVEAL, VERTEPORFIN",
author = "T. Leslie and Noemi Lois and Dina Christopoulou and Olson, {J. A.} and Forrester, {John Vincent}",
year = "2005",
doi = "10.1136/bjo.2004.046623",
language = "English",
volume = "89",
pages = "147--150",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression

AU - Leslie, T.

AU - Lois, Noemi

AU - Christopoulou, Dina

AU - Olson, J. A.

AU - Forrester, John Vincent

PY - 2005

Y1 - 2005

N2 - Aim: To report on visual and angiographic outcomes of a consecutive series of patients with inflammatory choroidal neovascular membranes (CNV) unresponsive to systemic immunosuppression treated with photodynamic therapy (PDT).Methods: The medical records of six consecutive patients with inflammatory CNVs that failed to respond to systemic immunosuppression and that later underwent PDT were retrospectively reviewed. Patient demographics, visual acuity, and fluorescein angiographic findings were evaluated.Results: There were five females and one male with a mean age of 40.8 years (range 35-58 years). Four patients had clinical features consistent with punctate inner choroidopathy and two with presumed ocular histoplasmosis. In all cases clinical signs of CNV activity, including subretinal fluid, subretinal blood, hard exudates, and/or recent decrease in visual acuity were present prior to PDT. All patients had been treated with high dose systemic immunosuppressants, which failed to induce regression of the CNV and/or to improve vision. The CNVs were subfoveal in five patients and juxtafoveal in one; all were classified as predominantly classic. Following PDT an improvement in vision occurred in all cases ( median improvement of 18 letters, range 3-42 letters). At last follow up, signs of decreased activity in the CNV were detected in all cases. Patients were followed for a median of 10 months (range 9-20 months).Conclusion: PDT appears to be a useful option in the management of patients with inflammatory CNVs unresponsive to immunosuppressive therapies.

AB - Aim: To report on visual and angiographic outcomes of a consecutive series of patients with inflammatory choroidal neovascular membranes (CNV) unresponsive to systemic immunosuppression treated with photodynamic therapy (PDT).Methods: The medical records of six consecutive patients with inflammatory CNVs that failed to respond to systemic immunosuppression and that later underwent PDT were retrospectively reviewed. Patient demographics, visual acuity, and fluorescein angiographic findings were evaluated.Results: There were five females and one male with a mean age of 40.8 years (range 35-58 years). Four patients had clinical features consistent with punctate inner choroidopathy and two with presumed ocular histoplasmosis. In all cases clinical signs of CNV activity, including subretinal fluid, subretinal blood, hard exudates, and/or recent decrease in visual acuity were present prior to PDT. All patients had been treated with high dose systemic immunosuppressants, which failed to induce regression of the CNV and/or to improve vision. The CNVs were subfoveal in five patients and juxtafoveal in one; all were classified as predominantly classic. Following PDT an improvement in vision occurred in all cases ( median improvement of 18 letters, range 3-42 letters). At last follow up, signs of decreased activity in the CNV were detected in all cases. Patients were followed for a median of 10 months (range 9-20 months).Conclusion: PDT appears to be a useful option in the management of patients with inflammatory CNVs unresponsive to immunosuppressive therapies.

KW - OCULAR HISTOPLASMOSIS SYNDROME

KW - PUNCTATE INNER CHOROIDOPATHY

KW - RANDOMIZED CLINICAL-TRIALS

KW - ANGIOID STREAKS

KW - MULTIFOCAL CHOROIDITIS

KW - LASER PHOTOCOAGULATION

KW - VISUAL PROGNOSIS

KW - SURGICAL REMOVAL

KW - SUBFOVEAL

KW - VERTEPORFIN

U2 - 10.1136/bjo.2004.046623

DO - 10.1136/bjo.2004.046623

M3 - Article

VL - 89

SP - 147

EP - 150

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

ER -